Full metadata record

DC Field Value Language
dc.contributor.authorMuddassar, M.-
dc.contributor.authorPasha, F. A.-
dc.contributor.authorChung, H. W.-
dc.contributor.authorYoo, K. H.-
dc.contributor.authorOh, C. H.-
dc.contributor.authorCho, S. J.-
dc.date.accessioned2024-01-20T23:34:37Z-
dc.date.available2024-01-20T23:34:37Z-
dc.date.created2021-09-03-
dc.date.issued2008-03-
dc.identifier.issn1110-7243-
dc.identifier.urihttps://pubs.kist.re.kr/handle/201004/133700-
dc.description.abstractResearch by other investigators has established that insulin-like growth factor-1 receptor (IGF-1R) is a key oncological target, and that derivatives of 1, 3-disubstituted-imidazo[ 1,5-alpha] pyrazine are potent IGF-1R inhibitors. In this paper, we report on our three-dimensional quantitative structure activity relationship (3D-QSAR) studies for this series of compounds. We validated the 3D-QSAR models by the comparison of two major alignment schemes, namely, ligand-based (LB) and receptor-guided (RG) alignment schemes. The latter scheme yielded better 3D-QSAR models for both comparative molecular field analysis (CoMFA) (q(2) = 0.53, r(2) = 0.95) and comparative molecular similarity indices analysis (CoMSIA) (q(2) = 0.51, r(2) = 0.86). We submit that this might arise from the more accurate inhibitor alignment that results from using the structural information of the active site. We conclude that the receptor-guided 3D-QSAR may be helpful to design more potent IGF-1R inhibitors, as well as to understand their binding affinity with the receptor. Copyright (c) 2008 M. Muddassar et al.-
dc.languageEnglish-
dc.publisherHINDAWI LTD-
dc.subjectGROWTH-FACTOR-I-
dc.subjectBREAST-CANCER-
dc.subjectCOMFA-
dc.subjectMOLECULES-
dc.subjectKINASE-
dc.subjectCOMSIA-
dc.subjectFIELD-
dc.subjectQSAR-
dc.titleReceptor guided 3D-QSAR: A useful approach for designing of IGF-1R inhibitors-
dc.typeArticle-
dc.identifier.doi10.1155/2008/837653-
dc.description.journalClass1-
dc.identifier.bibliographicCitationJOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY-
dc.citation.titleJOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.identifier.wosid000255761000001-
dc.identifier.scopusid2-s2.0-41149088721-
dc.relation.journalWebOfScienceCategoryBiotechnology & Applied Microbiology-
dc.relation.journalWebOfScienceCategoryMedicine, Research & Experimental-
dc.relation.journalResearchAreaBiotechnology & Applied Microbiology-
dc.relation.journalResearchAreaResearch & Experimental Medicine-
dc.type.docTypeArticle-
dc.subject.keywordPlusGROWTH-FACTOR-I-
dc.subject.keywordPlusBREAST-CANCER-
dc.subject.keywordPlusCOMFA-
dc.subject.keywordPlusMOLECULES-
dc.subject.keywordPlusKINASE-
dc.subject.keywordPlusCOMSIA-
dc.subject.keywordPlusFIELD-
dc.subject.keywordPlusQSAR-
dc.subject.keywordAuthor3D QSAR-
dc.subject.keywordAuthormolecular docking-
dc.subject.keywordAuthorreceptor-guided alignment-
dc.subject.keywordAuthorinhibitors-
Appears in Collections:
KIST Article > 2008
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE